Open original FDA record ↗Recall record
- FDA identifier
- Z-0809-2014
- Company in FDA record
- CryoLife, Inc.
- FDA classification date
- Jan 23, 2014
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Serological testing for the donor was performed with a blood sample that may have been hemodiluted due to the administration of normal saline to the donor prior to death.
Source facts
- Action
- CryoLife sent an Urgent Human Tissue Recall letter dated November 22, 2013, to all affected customers. The letter identified the product, the problem, and the action to be taken by the customer. Customers were instructed to contact CryoLife to arrange for the return of the affected product. If the affected product had been implanted or discarded, customers should provide information regarding the status of the affected product on the attached self-addressed postcard. Customers with questions were instructedto contact the Field Assurance Department at 800-438-8285. For questions regarding this recall call 770-419-3355.
- Initiated
- 2013-11-22
- Root cause
- Other
- Terminated
- 2014-02-20
- Distribution
- US distribution in CA.
- Recall number
- Z-0809-2014
- Recall status
- Terminated
- CDRH record ID
- 124885
- FDA classified
- 2014-01-23
- Recall event number
- 67182